H. Lehmann

发表

[On the pharmacology and toxicology of silymarin, an antihepatotoxic active principle from Silybum marianum (L.) Gaertn].

G. Vogel, G. Hahn, H. Lehmann, 1968, Arzneimittel-Forschung.

Inhibition by the Combined Ca2+ and 5‐HT2 Receptor Antagonist Nexopamil (LU 49938) of Intracoronary Thrombus Formation in a Canine Model of Arterial Stenosis and Intimal Damage

M. Kirchengast, K. Rübsamen, H. Lehmann, 1993, Journal of cardiovascular pharmacology.

6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities.

J. Gries, R. Kretzschmar, H. Lehmann, 1983, Journal of medicinal chemistry.

The puzzle of Alzheimer's disease (AD).

H. Lehmann, 1992, Medical hypotheses.

Pharmacology of amezinium, a novel antihypotensive drug. II. Examination of cardiovascular effects.

M. Raschack, R. Kretzschmar, H. Lehmann, 1981, Arzneimittel-Forschung.

Pharmacology of amezinium, a novel antihypotensive drug. I. Comparative studies of the effect on blood pressure and heart rate.

J. Gries, H. Lehmann, D. Lenke, 1981, Arzneimittel-Forschung.

On the influence of amezinium on various vascular regions of the dog.

M. Raschack, R. Kretzschmar, H. Lehmann, 1983, General pharmacology.

Ca2+ Antagonists — Mode of Action and Pharmacodynamics

H. Lehmann, 1988 .

NEW β-SYMPATHOLYTIC AGENTS: SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF ISOMERIC BENZOTHIAZOLE AND BENZOXAZOLE DERIVATIVES

F. Frickel, A. Franke, J. Gries, 1981 .

[New beta-sympatholytic agents. Synthesis and pharmacological activity of isomeric benzthiazole and benzoxazole derivates (author's transl)].

F. Frickel, A. Franke, J. Gries, 1980, Arzneimittel-Forschung.